MedTrace Logo

Cardiovascular Effects of EVOO in Healthy Reproductive-aged Women

NCT03820336 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-04-17

No results posted yet for this study

Summary

This study aims to compare changes in cardiovascular function and markers of inflammation and metabolic dysfunction in women randomized to treatment with extra virgin olive oil (EVOO) versus those randomized to treatment with a control oil low in oleic acid and phenols for 8 weeks.

Conditions

Interventions

DIETARY_SUPPLEMENT

Extra Virgin Olive Oil

Subjects will consume 45 ml (40 g) of EVOO daily for 8 weeks.

DIETARY_SUPPLEMENT

Control Oil

Subjects will consume 45 ml (40 g) of a control sunflower seed oil daily for 8 weeks.

Sponsors & Collaborators

  • University of Vermont Medical Center

    lead OTHER

Principal Investigators

  • Erin A Morris, MD · University of Vermont Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03820336 on ClinicalTrials.gov